by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Celmade Warning Letter Details

Warning Letter

Celmade

South Korea

Issue DateSeptember 14, 2026

FEI NumberN/A

Violations2

CountrySouth Korea

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Review of Website/Unapproved New Drug/Misbranded

Celmade FDA Warning Letter, September 14, 2026